Telehealth helps breast cancer patients adhere to endocrine therapy by reducing barriers and enabling timely clinical support, study finds.

Viking Therapeutics develops clinical-stage therapies for metabolic and endocrine disorders, aiming to address unmet medical needs.

Individuals who are sourcing unregulated medicines and who are seen by the NHS Children and Young People’s Gender Service will be advised to discontinue the medicine. The NHS Children and Young People ...

See how breast cancer endocrine and targeted drugs inform endometrial and ovarian care—tamoxifen, CDK4/6 combos, and T-DXd. In an interview with Targeted Oncology, Natalie Berger, MD, hematologist and ...

AstraZeneca has also filed an oral SERD, camizestrant, targeting use of the drug in patients with advanced HR-positive breast ...

persevERA is the first of two distinct Phase III studies in the first-line setting; the pionERA study of giredestrant in combination with physician’s choice of cyclin-dependent kinase (CDK)4/6 ...

RIVKIN Aesthetics reports the rise of weight loss drugs like GLP-1 is reshaping aesthetics, with many new patients seeking ...

GLP-1 drugs like Ozempic and Mounjaro show no increased thyroid cancer risk in human data, despite lawsuits over stomach ...

Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...

A 15-year study shows that the drug pergolide is an effective treatment for pituitary pars intermedia dysfunction.

Adjuvant endocrine therapy reduces cancer recurrence and improves overall survival in hormone receptor–positive breast cancer. Maintaining long-term adherence to endocrine therapy can be challenging, ...

The U.S. Food and Drug Administration is reportedly mulling whether more prescription drugs should be sold over the counter (OTC) at pharmacies. In an interview on Wednesday, FDA commissioner Martin ...